Abstracts by keywords: digitization
The digitalization of medicine makes it possible to detect diseases more quickly, monitor them better and take new findings into account promptly when making individual therapy decisions. The chemical and pharmaceutical industries are also facing this change, even though they are in the middle of the commercial economy in terms of digitalization in Germany. The current focus is primarily on the activities of Big Tech companies or digital healthcare start-ups and their approaches to drug development using big data or AI. However, little attention is paid to how the pharmaceutical industry, with its products that often require explanation, positions itself to communicate relevant information about its products and services to patients and medical professionals using digital tools and service innovations. The perspective of the patient without previous medical training must be taken into account, as well as the need for scientifically based information from medical professionals. The following comments are therefore dedicated to these new approaches to medical information.
28.07.2020
The gross value added in the core area of the healthcare industry was around 350 billion euros in 2017. This corresponds to around 12 percent of the gross domestic product. The health sector is not only seen as an important economic sector per se, but also has great economic benefits, as health is seen as the basis for creativity and economic success (BMG 2019a, WHO). In the current discussion, in addition to medical progress and technological achievements, holistic considerations play a role, which lead to better care and can be achieved through the digital networking of the actors. Compared to other European countries, Germany lags behind when it comes to digital offerings, and the welcome initiative to establish a “Global Health Hub” cannot hide this.